Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Falling Comet

logo
Alivus Life Sciences Ltd.
27 Jan 2023, 12:00AM
880.55
-0.33%
BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
Number of FII/FPI investors increased from 92 to 98 in Dec 2025 qtr.
More from Alivus Life Sciences Ltd.
Recommended